Publication: Estudio comparativo radiográfico del tratamiento de pulpotomía realizado con formocresol y con sulfato férrico en molares temporales
Loading...
Official URL
Full text at PDC
Publication Date
2012
Authors
Advisors (or tutors)
Editors
Journal Title
Journal ISSN
Volume Title
Publisher
Citations
Exportar
Abstract
Description
UCM subjects
Unesco subjects
Keywords
Citation
1. Cortés Lillo O, Boj Quesada JR. Tratamientos pulpares en la dentición temporal. En Boj JR, Catalá M, García-Ballesta C, Mendoza A, Planells P, editores. Odontopediatría. La evolución del niño al adulto joven. Madrid: Ed. Ripano SA; 2011, p 337-350.
2. Nadin G, Goel BR, Yeung CA, Glenny AM. Tratamiento pulpar para caries extensas en dentición temporal (Revisión Cochrane traducida). En: La Biblioteca Cochrane Plus, 2008 Número 2. Oxford: Update Software Ltd. Tomada de: http://www.update-software.com el 19 de febrero de 2011.
3. Fucks AB. Vital pulp therapy with new materials for primary teeth: new directions and treatment perspectives. Pediatr Dent. 2008; 30: 211-9.
4. Weisshaar S. Endodoncia en las denticiones primaria y mixta. Indicaciones, materiales y procedimientos para el tratamiento pulpar. Quintessence Int. 2001;52:371-9.
5. Ranly DM, García-Godoy F. Current and potential pulp therapies for primary and young permanent teeth. J Dent. 2000;28:153-61.
6. Maroto Edo M, Saavedra Marbán G y Barbería Leache E. Tratamientos pulpares en dientes temporales y permanentes jóvenes. En: Manual de clínica Odontopediátrica. Magíster de Odontopediatría UCM. IBSN-13: 978-84-690-5255-6. Depósito Legal Nº M-27462-2006. Registro de la Propiedad Intelectual 16/ 2007 /4799.
7. Magnusson BO, Koch G, Poulsen S. Odontopediatría. Enfoque sistemático. Barcelona. Salvat Editores SA, 1985.
8. Azabal Arroyo M. Patología pulpar y periapical. En: Patología y terapéutica dental. Editor: García-Barbero J. Madrid. Editorial Síntesis. 1997.
9. Rodd HD, Waterhouse PJ, Fucks AB, Fayle SA, Moffatuk MA. Pulp therapy for primary molars. National Clinical Guidelines in Paediatric Dentistry. Int J Paediatr Dent. 2006; 16 (Suppl. 1): 15–23.
10. Ricketts DNJ, Kidd EAM, Innes N, Clarkson J. Complete or ultraconservative removal of decayed tissue in unfilled teeth. Cochrane Database Syst Rev 2006; CS003808.
11. Farooq NS, Coll JA, Kuwabara A, Shelton P. Success rates of formocresol pulpotomy and indirect pulp treatment of deep dentinal caries in primary teeth. Pediatr Dent. 2000; 22: 278-86.
12. Casas MJ, Layug MA, Kenny DJ, Johnston DH, Judd DH. Two year outcomes of primary molar ferric sulfate pulpotomy and root canal therapy. Pediatr Dent. 2003; 25(2):97-102.
13. Matencio-Garcés A, Sáez-Martínez S, Guinot-Jimeno F, Cuadros-Fernández C, Bellet-Dalmau LJ. Alternativas al formocresol a lo largo de la historia. Revisión de la literatura. Dentum 2010; 10(3):102-112.
14. Simancas-Pallares MA, Díaz-Caballero AJ, Luna-Ricardo LM. Mineral trioxide aggregate in primary teeth pulpotomy. A systematic literature review. Med Oral Patol Oral Cir Bucal. 2010; 15 (6):e942-6.
15. Moretti ABS, Sakai VT, Oliveira TM, Fornetti APC, Santos CF, Machado MAAM, Abdo RCC. The effectiveness of mineral trioxide aggregate, calcium hydroxide and formocresol for pulpotomies in primary teeth. Int Endod J. 2008; 41: 547–55.
16. Maroto-Edo M. Estudio clínico del agregado trióxido mineral en pulpotomías de molares temporales. Tesis Doctoral. Madrid: Universidad Complutense de Madrid, servicio de publicaciones, 2003.
17. Cardoso C. Estudio clínico del agregado trióxido mineral en pulpotomías de molares temporales: comparación de resultados con MTA gris y MTA blanco. Tesis Doctoral. Madrid: Universidad Complutense de Madrid, servicio de publicaciones, 2010.
18. Aguado JM, De la Cruz-Cerdá I, Maroto M, Barbería E. Posibilidades terapéuticas del agregado trióxido mineral (MTA) en Odontopediatría. JADA. 2009; 4(4): 185-193.
19. Hingston EJ, Parmar S, Hunter ML. Vital pulpotomy in the primary dentition: attitudes and practices of community dental staff in Wales. Int J Paediatr Dent. 2007;17(3):186-91.
20. Aeinehchi M, Dadvand S, Fayazi S, Bayat-Movahed S. Randomized controlled trial of mineral trioxide aggregate and formocresol for pulpotomy in primary molar teeth. Int Endod J. 2007; 40: 261–267.
21. Peng L, Ye L, Guo X, Tan H, Zhou X, Wang C, Li R. Evaluation of formocresol versus ferric sulphate primary molar pulpotomy: a systematic review and meta-analysis. Int Endod J. 2007; 40: 751–757.
22. Peng L, Ye L, Tan H, Zhou X. Evaluation of the formocresol versus mineral trioxide aggregate primary molar pulpotomy: a meta-analysis. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2006; 102(6): e40-e44.
23. Fei AL, Udin RD, Johnson R. A clinical study of ferric sulphate as a pulpotomy agent in primary teeth. Pediatr Dent.1991; 13(6): 327-32.
24. Ansari G, Ranjpour M. Mineral trioxide aggregate and formocresol pulpotomy of primary teeth: a 2-year follow-up. Int Endod J. 2010; 43: 413–418.
25. Srinivasan V, Patchett CL, Waterhouse PJ. Is there life after Buckley’s formocresol? Part I – A narrative review of alternative interventions and materials. Int J Paed Dent. 2006; 16: 117-27.
26. Vargas KG, Packham B. Radiographic success of ferric sulfate and formocresol pulpotomies in relation to early exfoliation. Pediatr Dent. 2005; 27: 233–7.
27. Calatayud J, Casado I, Álvarez C. Análisis de los estudios clínicos sobre la eficacia de las técnicas alternativas al formocresol en las pulpotomías de dientes temporales. Av. Odontoestomatol. 2006; 22 (4): 229-239.
28. Nunn JH, Smeaton I, Gilory J. The development of formocresol as a medicament for primary molar pulpotomy procedures. J Dent Child. 1996; 63(1): 51-3.
29. Doyle WA, McDonald RE, Mitchel DF. Formocresol versus calcium hydroxide in pulpotomy. ASDJ J Dent Child. 1962; 29: 86-97.
30. Spedding RH, Mitchel DF, McDonald RE. Formocresol and calcium hydroxide therapy. J Dent Res. 1965; 44: 1023-34.
31. Berger JE. Pulp tissue reaction to formocresol and zinc oxide-eugenol. J Dent Child. 1965; 32: 13-28.
32. Redig DF. A comparison and evaluation of two formocresol pulpotomy technics using ―Buckley´s‖ formocresol. J Dent Child. 1968; 35(1): 22-30.
33. Straffon LH, Han SS. Effects of varying concentrations of formocresol on RNA syntheis of connective tissues in sponge implants. Oral Surg Oral Med Oral Pathol. 1970; 29(6): 915-25.
34. Morawa AP, Straffon LH, Han SS, Corpron RE. Clinical evaluation of pulpotomies using diluted formocresol. ASDC J Dent Child.1975; 42(5): 360-3.
35. García-Godoy F, Ranly DM. Clinical evaluation of pulpotomies with ZOE as the vehicle for glutaraldehyde. Pediatr Dent. 1987; 9(2): 144-6.
36. Primosch RE, Glomb TA, Jerrell RG. Primary tooth pulp therapy as taught in predoctoral pediatric dental programs in the United States. Pediatr Dent.1997;19(2): 118-22.
37. Kurji ZA, Sigal MJ, Andrews P, Titley K. A Retrospective Study of a Modified 1-minute formocresol pulpotomy technique. Part 1: Clinical and radiographic findings. Pediatr Dent. 2011; 33: 131-8.
38. King SR, McWhorter AG, Seale NS. Concentration of formocresol used by pediatric dentist in primary tooth pulpotomy. Pediatr Dent. 2002; 24: 157-9.
39. Biondi AM, Cortese SG, Ortolani A, Benchuya C, Tudesco M. Pulpotomías en molares primarios. Evaluación clínico radiográfica de formocresol o trióxido mineral agregado. Revista de la Facultad de Odontología (UBA). 2008; 54: 13-7.
40. Hill S, Berry CW, Seale NS, Kaga M. Comparison of antimicrobial and cytotoxic effects of glutarldehyde and formocresol. Oral Surg Oral Med Oral Pathol. 1991; 71: 89-95.
41. Lewis B. Formaldehyde in dentistry: a review for the millennium. J Clin Ped Dent. 1998; 22(2): 167-77.
42. International Agency for Research on Cancer, World Health Organization. IARC classifies formaldehyde as carcinogenic to humans. Press release nº 153, June 15, 2004. http://www.iarc.fr/ENG/Press_Releases/archives/pr153a.html (Visto el 12 de Marzo de 2011).
43. Patchett CL, Srinivasan V, Waterhouse PJ. Is there life after Buckley’s formocresol? Part II – Development of a protocol for the management of extensive caries in the primary molar. Int J Paed Dent. 2006; 16: 199–206.
44. Ranly DM, Horn D, Zislis T. The Effect of Alternatives to formocresol on Antigenicity of Proteins. J Dent Res. 1985; 64(10): 1225-28.
45. Camp JH, Barrett EJ, Pulver F. Endodoncia pediátrica: tratamiento endodóncico en la dentición temporal y permanente joven. En: Cohen S, Burns RC, editores. Vías de la pulpa. 9ªed. Madrid: Mosby Elsevier; 2008.
46. Méndez Blanco VM, Alvarez Congost C, Alvarez Brasa C. Pulpotomías en la dentición decidua: buscando alternativas. Odontología Pediátrica. 1995; 4(3): 145-9.
47. Ketley CE, Goodman JR. formocresol toxicity: is there a suitable alternative for pulpotomy of primary molars? Int J Paed Dent. 1991; 2: 67-72.
48. Alacam A. Pulpal tissue changes following pulpotomies with formocresol, glutaraldehyde-calcium hydroxide, glutaraldehyde-cinc oxide eugenol pastes in primary teeth. J Pedod. 1989; 13: 123-32.
49. Segura JJ, Jiménez Rubio A, Guerrero JM, Calvo JR, Feito JJ. Effect in vitro of Tiffel (formocresol-eugenol) on macrophage adhesion. Int Endod J. 1998; 31: 112-6.
50. Rusmah M. Pulpal tissue reaction to buffered glutaraldehyde. J Clin Ped Dent. 1992; 16(2): 101-6.
51. Fernández Domínguez H, Mendoza Mendoza A, Solano Reina E. Pulpotomía: estudio comparativo entre glutaraldehído al 4% y formocresol al 20% en dientes temporales vitales. Odontología Pediátrica. 2000; 8(1): 19-25.
52. Ranly DM. Assessment of the systemic distribution and toxicity of formaldehyde following pulpotomy treatment. Part one. ASDC J Dent Child. 1985; 52(6): 431-4.
53. Swenberg JA, Kerns WD, Mitchell RI, Gralla EJ, Pavkov KL. Induction of squamous cell carcinomas on the rat nasal cavity by inhalation exposure to formaldehyde vapor. Cancer Res. 1980; 40(9): 3398-402.
54. Lewis B, Chestner S. Formaldehyde in dentistry: a review of mutagenic and carcinogenic potential. J Am Dent Assoc. 1981; 103(3): 429-34.
55. Milness AR. Persuasive evidence that formocresol use in pediatric dentistry is safe. J Can Dent Assoc. 2006; 72(3): 247–8.
56. Zarzar PA, Rosenblatt A, Takahashi CS, Takeuchi PL, Costa Júnior LA. Formocresol mutagenicity following primary tooth pulp therapy: an in vivo study. J Dent. 2003; 31: 479–485.
57. Fuks AB, Holan G, Davis JM, Eidelman E. Ferric sulfate versus dilute formocresol in pulpotomized primary molars: long-term follow up. Pediatr Dent. 1997; 19(5): 327-30.
58. Fucks AB, Eidelman E, Cleaton-Jones P, Michaeli Y. Pulp response to ferric sulfate, diluted formocresol and IRM in pulpotomized primary baboon teeth. J Dent Child. 1997; 64: 254-9.
59. Ibricevic H, Al-Jame Q. Ferric sulfate as pulpotomy agent in primary teeth: twenty month clinical follow-up. J Clin Pediatr Dent. 2000; 24(4): 269-272.
60. Huth KC, Paschos E, Hajek-Al-Khatar N, Hollweck R, Crispin A, Hickel1 R, Folwaczny M. Effectiveness of 4 Pulpotomy Techniques— Randomized Controlled Trial. J Dent Res. 2005;84(12):1144-1148.
61. Burnett S, Walker J. Comparison of ferric sulfate, formocresol, and a combination of ferric sulfate/formocresol in primary tooth vital pulpotomies: A retrospective radiographic survey. J Dent Child. 2002; 69: 44-48.
62. Smith NL, Seale NS, Nunn ME. Ferric sulphate pulpotomy in primary molars: a retrospective study. Pediatr Dent. 2000; 22(3): 192-199.
63. Sonmez D, Sari S, Cetinbas T. A comparison of four pulpotomy techniques inprimary molars: a long term follow up. J Endod 2008; 34(8): 950-5.
64. Bellet LJ, Guinot F, Arregui M. Aplicaciones clínicas del MTA en Odontopediatría. Dentum. 2006; 6(3): 96-102.
65. Salako N, Joseph B, Ritwik P, Salonen J, John P, Junaid TA. Comparison of bioactive glass, mineral trioxide aggregate, ferric sulfate and formocresol as pulpotomy agents in rat molar. Dent Traumatol. 2003; 19: 314-320.
66. Maroto-Edo M, Barbería-Leache E, Planells del Pozo P. Estudio clínico del agregado trióxido mineral en pulpotomías de molares temporales: estudio piloto a 15 meses. RCOE. 2004; 9(1): 23-30.
67. Maroto M, Barbería E, Vera V, García-Godoy F. Dentin bridge formation after white mineral trioxide aggregate (white MTA) pulpotomies in primary molars. Am J Dent. 2006; 19: 75-9.
68. Noorollahian H. Comparison of mineral trioxide aggregate and formocresol as pulp medicaments for pulpotomies in primary molars. Br Dent J. 2008; 204: E20. DOI: 10.1038/sj.bdj.2008.319
69. Cardoso-Silva C, Barbería E, Maroto M, García-Godoy F. Clinical study of Mineral Trioxide Aggregate in primary molars. Comparison between Grey and White MTA—A long term follow-up (84 months). J Dent. 2011; 39:187-193.
70. Conti TR, Sakai VT, Fornetti APC, Moretti ABS, Oliveira TM, Lourenço-Neto N, Machado MAAM, Abdo RCC. Pulpotomies with portland cement in human primary molars. J Appl Oral Sci. 2009; 17(1): 66-9.
71. Prabhakar AR, Bedi S. Effect of glutaraldehyde and ferric sulfate on shear bond strength of adhesives to primary dentin. J Indian Pedod Prev Dent. 2008 Supplement: S109-113. Tomado de: http://jisppd.com el 28 de mayo de 2011.
72. Loh A, O´Hoy P, Tran X, Charles R, Hughes A, Kubo K, Messer LB. Evidence-based assessment: evaluation of the formocresol versus ferric sulfate primary molar pulpotomy. Pediatr Dent. 2004; 26(5): 401-409.
73. Zurn D, Seale NS. Light-cured Calcium Hydroxide vs formocresol in human primary molar pulpotomies: A randomized controlled trial. 2008; 30(1): 34-41.
74. Toomarian L, Fekrazad R, Sharifi D, Baghaei M, Rahimi H, Eslami B. Histopathological evaluation of pulpotomy with Er,Cr:YSGG laser vs formocresol. Lasers Med Sci. 2008; 23: 443–450.
75. Bahrololoomi Z, Moeintaghavi A, Emtiazi M, Hosseini G. Clinical and radiographic comparison of primary molars after formocresol and electrosurgical pulpotomy: A randomized clinical trial. Indian J Dent Res. 2008; 19(3): 219-23.
76. Casas MJ, Kenny DJ, Johnston DH, Judd DH, Layug MA. Outcomes of vital primary incisor ferric sulfate pulpotomy and root canal therapy. J Can Dent Assoc. 2004; 70(1): 34–8.
77. Vargas KG, Packham B, Lowman D. Preliminary evaluation of sodium hypochlorite for pulpotomies in primary molars. Pediatr Dent. 2006; 28 :511-517.
78. Vostatek SF, Kanellis MJ, K Weber-Gasparoni, Gregorsok RL. Sodium hypochlorite pulpotomies in primary teeth: a retrospective assessment. Pediatr Dent. 2011; 33: 327-32.
79. Saltzman B, Sigal M, Clockie C, Rukavina J, Titley K, Kulkarn GV. Assessment of a novel alternative to conventional formocresol-zinc oxide eugenol pulpotomy for the treatment of pulpally involved human primary teeth: diode laser-mineral trioxide aggregate pulpotomy. Int J Paed Dent. 2005; 15: 437–447.
80. Nakashima M. The induction of reparative dentine in the amputated dental pulp of the dog by bone morphogenetic protein. Arch Oral Biol. 1990; 35: 493-7.
81. Shayegan A, Petein M, Abbeele AV. Beta-tricalcium phosphate, white mineral trioxide aggregate, white Portland cement, ferric sulfate, and formocresol used as pulpotomy agents in primary pig teeth. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2008; 105: 536-42.
82. American Academy of Pediatric Dentistry. Guideline on pulp therapy for primary and immature permanent teeth. Reference Manual 2009-10. Pediatr Dent. 2009; 31: 179-84.
83. Erdem AP, Guven Y, Balli B, Ilhan B, Sepet E, Ulukapi I, Aktoren O. Success rates of mineral trioxide aggregate, ferric sulfate, and formocresol pulpotomies: a 24-month study. Pediatr Dent. 2011; 33: 165-70.
84. Kurji ZA, Sigal MJ, Andrews P, Titley K. A Retrospective Study of a Modified 1-minute formocresol pulpotomy technique. Part 2: Effect on exfoliation times and successors. Pediatr Dent. 2011; 33: 139-43.
85. Carrasco JL, Hernán MA. Estadística multivariante en ciencias de la vida. Fundamentos, métodos y aplicación. 1ª Ed. Madrid: Ed. Ciencia; 1993.
86. Calatayud J, Martín G. Bioestadística en la investigación odontológica. Madrid. Ed. Pues; 2002.